Smith David Ross 4

Accession 0001127602-22-008258

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:13 PM ET

Size

23.0 KB

Accession

0001127602-22-008258

Insider Transaction Report

Form 4

Period: 2022-03-03

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL

Smith David Ross

Corporate Executive VP & CFO

Transactions

Exercise/Conversion
Common Stock
2022-03-03$144.67/sh+3,304$477,990→ 32,969 total
Sale
Common Stock
2022-03-03$285.16/sh−387$110,357→ 25,819 total
Exercise/Conversion
Stock Options (Right to Buy)
2022-03-03−3,846→ 0 total
Exercise: $109.34From: 2019-02-23Exp: 2023-02-23→ Common Stock (3,846 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2022-03-03−3,304→ 3,305 total
Exercise: $144.67From: 2020-02-22Exp: 2024-02-22→ Common Stock (3,304 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2022-03-03−1,815→ 5,446 total
Exercise: $179.66From: 2021-05-29Exp: 2030-05-29→ Common Stock (1,815 underlying)
Exercise/Conversion
Common Stock
2022-03-03$109.34/sh+3,846$420,522→ 29,665 total
Exercise/Conversion
Common Stock
2022-03-03$179.66/sh+1,815$326,083→ 34,784 total
Sale
Common Stock
2022-03-03$281.49/sh−3,825$1,076,716→ 30,959 total
Sale
Common Stock
2022-03-03$282.56/sh−2,606$736,361→ 28,353 total
Sale
Common Stock
2022-03-03$283.41/sh−1,289$365,316→ 27,064 total
Sale
Common Stock
2022-03-03$284.58/sh−858$244,171→ 26,206 total

Footnotes (5)

[F1]This transaction was executed in multiple trades at prices ranging from $280.98 to $281.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $281.98 to $282.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $283.00 to $283.7. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]This transaction was executed in multiple trades at prices ranging from $284.28 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]This transaction was executed in multiple trades at prices ranging from $285.09 to $285.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

→

Entity typeother

Related Parties

filerCIK 0001650274

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 4:13 PM ET
Size: 23.0 KB

View on SEC.gov